Insider Ledger

NAUT insider buying and SEC filings, explained

Nautilus Biotechnology, Inc. · CIK 1808805

Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov

Company profile

Exchanges
Nasdaq
Industry (SIC)
Laboratory Analytical Instruments
Fiscal year end
Dec 31
Former names
ARYA Sciences Acquisition Corp III

Insider activity in the last 12 months

Bought
$65K
Insiders who bought
1
Sold (not marked 10b5-1)
$11.8M
Planned sales (10b5-1)
$0

Insider purchases and sales, last 12 months

TradedTypeWhat was filedSource
Jun 2, 2026SaleMarc L Andreessen (10% owner) sold 5,000,000 shares indirectly (by entity) at $2.35 ($11.8M). Holdings by entity down 28% to 11,682,032 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 5 other reporting owners.SEC filing
Filed Jun 4, 2026
Mar 4, 2026Purchase (code P)Sujal M Patel (CEO and Director) bought 25,000 shares at about $2.61 ($65K), reported as a purchase (code P). Holdings up <1% to 10,366,721 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Mar 4, 2026
Nov 6, 2025Purchase (code P)Kentaro Suzuki (Chief Marketing Officer) bought 4,000 shares at $1.49 ($6K), reported as a purchase (code P). New position of 4,000 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Nov 10, 2025

12 routine transactions (such as grants, option exercises or tax withholding) are not listed.

Cluster buys

No cluster buys in the last 12 months.

Red flags

No red flags in the last 12 months.

Key events

No key events in the last 12 months.

8-K filings, last 12 months

No 8-K filings in the last 12 months.

Red flags are objective triggers only: the item or form filed, never an opinion.

Follow NAUT in the Insider Ledger app

A plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.

Get the app